Sex differences in TNFR2 signaling mechanisms following acute surgical ischemia
急性手术缺血后TNFR2信号传导机制的性别差异
基本信息
- 批准号:7672626
- 负责人:
- 金额:$ 5.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-01 至 2010-06-30
- 项目状态:已结题
- 来源:
- 关键词:AblationAcuteAngiogenic FactorApoptoticCardiac Surgery proceduresCardiopulmonary BypassEstrogensExhibitsFemaleGenderGrowth FactorHeart DiseasesInflammationInjuryInterleukin-1Interleukin-6IschemiaMAPK14 geneMAPK8 geneMEKsMediatingMediator of activation proteinMyocardialMyocardial IschemiaMyocardial dysfunctionOperative Surgical ProceduresPatientsPharmacotherapyPlayProductionRecoveryRecovery of FunctionReperfusion InjuryReperfusion TherapyResistanceRoleSex CharacteristicsSignal TransductionTNF geneTumor Necrosis Factor ReceptorUp-RegulationVascular Endothelial Growth FactorsWomancytokinedesignheart cellheart functionimprovedmalemenpublic health relevance
项目摘要
DESCRIPTION (provided by applicant): Myocardial inflammation occurs following cardiopulmonary bypass in patients undergoing cardiac surgery and plays a crucial role in myocardial dysfunction following ischemia-reperfusion (I/R) injury. Gender disparities exist in myocardial I/R injury (1), and recent studies suggest that females exhibit enhanced protection from I/R due to an inherent resistance in detrimental TNF receptor 1 (TNFR1) signaling (2). Estrogen has been implicated as a mediator of TNFR1 signaling resistance, but it is likely that estrogen facilitates these beneficial effects through other signaling cascades, including the upregulation of angiogenic factors such as VEGF. The role that TNF receptor 2 (TNFR2) may play in facilitating TNFR1 signaling resistance, however, has yet to be elucidated. We therefore hypothesize that: 1) TNFR2 mediates myocardial recovery after I/R, and has a greater impact on myocardial function, proinflammatory cytokine production, and apoptotic signaling in females as compared to males; 2) TNFR2 mediates increased myocardial protection in females through the production of vascular endothelial growth factor (VEGF); and 3) ablation of both TNFR1 and TNFR2 will equalize gender differences seen after myocardial injury. Therefore, the specific aims of this study are to: 1. determine whether improved functional recovery after ischemia/reperfusion is mediated by TNFR2 signaling, and if so, whether TNFR2 ablation worsens myocardial recovery to a greater degree in females 2. Determine if TNFR2 ablation increases myocardial TNF, IL-1, and IL-6; decreases VEGF; increases MARK signaling (p38, ERK, MEK, JNK), and increases proapoptotic signaling to a greater degree in females 3. determine if simultaneous ablation of both TNF receptors 1 and 2 equalizes gender differences in function. PUBLIC HEALTH RELEVANCE: Females have better heart function after injury. Therefore, by understanding the signals that female heart cells use to improve their function after injury, we may be able to design new drugs and therapies to treat heart disease in both men and women.
描述(由申请人提供):接受心脏手术的患者在体外循环后发生心肌炎症,并在缺血-再灌注(I/R)损伤后的心肌功能障碍中起关键作用。心肌I/R损伤存在性别差异(1),最近的研究表明,由于有害的TNF受体1(TNFR 1)信号传导的固有抗性,女性对I/R的保护作用增强(2)。雌激素被认为是TNFR 1信号抗性的介导者,但雌激素可能通过其他信号级联促进这些有益作用,包括血管生成因子如VEGF的上调。然而,TNF受体2(TNFR 2)在促进TNFR 1信号传导抗性中可能发挥的作用尚未阐明。因此,我们假设:1)TNFR 2介导I/R后的心肌恢复,并且与男性相比,对女性的心肌功能、促炎细胞因子产生和凋亡信号传导具有更大的影响; 2)TNFR 2通过产生血管内皮生长因子(VEGF)介导女性的心肌保护增加; 3)TNFR 1和TNFR 2的消融将平衡心肌损伤后观察到的性别差异。因此,本研究的具体目的是:1.确定缺血/再灌注后改善的功能恢复是否由TNFR 2信号传导介导,如果是,TNFR 2消融是否在更大程度上促进女性心肌恢复。确定TNFR 2消融是否增加心肌TNF、IL-1和IL-6;降低VEGF;增加MARK信号传导(p38、ERK、MEK、JNK),并在更大程度上增加女性中的促凋亡信号传导3。确定同时消融TNF受体1和2是否能平衡功能上的性别差异。公共卫生相关性:女性受伤后心脏功能更好。因此,通过了解女性心脏细胞在受伤后用于改善其功能的信号,我们可能能够设计新的药物和疗法来治疗男性和女性的心脏病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brent Richard Weil其他文献
Brent Richard Weil的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 5.01万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 5.01万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 5.01万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 5.01万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 5.01万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 5.01万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 5.01万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 5.01万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 5.01万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 5.01万 - 项目类别:
Operating Grants